Clinical Trial Update: Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating treatment of acute joint bleeds in patients with hemophilia A or B who have inhibitors; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• NovoSeven RT (Recombinant activated factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 2 | Status: COMPLETED | Results posted: 2014-12-25